Navigation Links
Genoptix Reports Strong Financial Results for the Second Quarter and Raises Guidance for Full-Year 2008

(in thousands, except per share data)

Three Months Ended Six Months Ended

June 30, June 30,

Pro Forma Pro Forma

2008 2007 2008 2007

(in thousands, except per share data)


Pro forma net income allocable to

common stockholders $5,571 $3,767 $10,578 $5,092


Weighted average shares of common

stock outstanding 16,380 230 16,283 214

Weighted average unvested shares of

common stock subject to repurchase (43) (52) (48) (48)

Adjustments to reflect the weighted

average effect of the assumed

conversion of convertible preferred

stock - 11,032 - 11,032

Pro forma weighted average shares of

common stock outstanding - basic 16,337 11,210 16,235 11,198

Dilutive effect of common equivalent

shares 1,175 1,548 1,272 1,547

Pro forma weighted average shares of

common stock outstanding - diluted 17,512 12,758 17,507 12,745

Pro forma net income per share:

Basic $0.34 $0.34 $0.65 $0.45

Diluted $0.32 $0.30 $0.60 $0.40

(1) As a result of the conversion of the Company's preferred stock into 11,032 shares of common stock upon completion of the Company's initial public offering in November 2007, there is a lack of comparability in the basic and diluted net income per share amounts for the periods presented above.

SOURCE Genoptix, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9

Related medicine news :

1. Genoptix Reports Strong Financial Results for First Quarter 2008
2. Genoptix Announces Participation at the Bank of America 2008 Healthcare Conference
3. Genoptix Announces 2008 Annual Stockholders Meeting and Date of Record
4. Genoptix Announces Participation at Lehman Brothers 11th Annual Global Health Care Conference
5. Genoptix Announces Participation at Cowen and Company 28th Annual Health Care Conference
6. Genoptix Announces Pricing of Secondary Public Offering
7. Genoptix Announces Filing of Registration Statement for Secondary Public Offering of Common Stock
8. Genoptix Reports Strong Financial Results for the Fourth Quarter and Full Year 2007
9. Genoptix, Inc. to Announce Fourth Quarter and Full Year 2007 Financial Results on February 12, 2008
10. Genoptix, Inc. Announces Pricing for Initial Public Offering
11. Poniard Pharmaceuticals Reports Second Quarter 2008 Financial Results and Corporate Update
Post Your Comments:
(Date:1/22/2015)... Recently, has added many trendy Champagne wedding ... revenues in the past three years. Today, the business announces ... According to the sales manager of the company, this is ... 2015. This point can be reflected on the discounted wedding ...
(Date:1/22/2015)... WASHINGTON, DC (PRWEB) January 22, 2015 ... conditions in vulnerable communities and cause financial distress to ... report by analysts at Howard University’s Center on Race ... of dollars in economic activity, payday loans at the ...
(Date:1/22/2015)... is a famous dress online store for wedding dresses ... latest collection of wedding dresses , and launches a site-wide ... wedding dress on your big day; the wedding gown is ... wants to find the most suitable wedding dress. Now, we ...
(Date:1/22/2015)... (PRWEB) January 22, 2015 Step into ... at the Science Museum of Virginia. Wicked Plants, the ... Wicked Plants unearths 75 poisonous, carnivorous and diabolical plants ... each room to uncover the biochemical, physical and neurological ...
(Date:12/26/2014)... 26, 2014 It is said that nothing ... Today,, the famous wedding dress supplier, shows its ... site-wide cocktail gown promotion. ,’s navy cocktail gowns ... they come in high fashion styles. Simple dresses in bright ...
Breaking Medicine News(10 mins):Health News:Weddingshe Announces A Special Offer On Its Popular Glamorous Wedding Dresses 2Health News:Howard University Spotlights the Economic Impact of Payday Lending in Southern States 2Health News:Find The Most Suitable Wedding Dress At 2Health News:Wicked Plants are taking over the Science Museum of Virginia 2Health Shows Its New Navy Cocktail Dresses For 2015 2
... receive short-term courses of antipsychotic medications are more likely ... not take the drugs, according to a report in ... one of the JAMA/Archives journals. , Newer antipsychotic drugs ... market for more than a decade and are commonly ...
... translated into 10% average decrease in lateral load on joint, ... a cane may help reduce the risk of knee osteoarthritis ... University of Melbourne in Australia. , The study included ... OA, an incurable joint disease that,s the leading cause of ...
... Scientists have created a tool for mopping up the ... disease. Emory University researchers engineered a virus to make ... whose mutant forms poison the brain cells of people ... of mice that make mutant huntingtin improves their ability ...
... that restricts the release of HIV-1 virus from human ... new approaches to treatment. The research is published in ... Scientists have known that most human cells contain a ... until now they have been uncertain about the factor,s ...
... getting that first pair , , FRIDAY, May 23 (HealthDay News) ... and are more honest than those who don,t wear glasses, ... addition, the researchers found that children tend not to judge ... a playmate, or likely athletic abilities. , These findings may ...
... Concur on Senate Budget,which Includes Elimination and Reductions to ... Many older,Illinoisans were left out of the Senate,s senior ... to several programs and,services that allow older residents to ... avoid costly and premature,institutional care. AARP is opposed to ...
Cached Medicine News:Health News:Short-term use of antipsychotics in older adults with dementia linked to serious adverse events 2Health News:Cane Use May Cut Progression of Knee Osteoarthritis 2Health News:'Intrabody' can mop up mutant protein in Huntington's disease model 2Health News:Kids Think Glasses Make Others Look Smart, Honest 2
(Date:1/23/2015)... 2015  Mallinckrodt plc (NYSE: MNK ) announced ... share repurchase program. The open-ended authorization permits the company ... ordinary shares. "Funding additional initiatives and ... we continue to pursue a range of focused growth ...
(Date:1/23/2015)... and BOSTON , January 23, 2015 ... discovery and development company, is delighted to announce that the ... awarded to Miles Congreve (Vice President of Chemistry), ... Malcolm Weir (Chief Executive Officer and co-founder) for ...
(Date:1/22/2015)... a privately held medical device company, announced today that ... ITOCHU Corporation (Tokyo Stock Exchange TYO: 8001) to sell ... cancer in Japan . ViewRay,s technology, ... only MRI-guided radiation therapy system that images and treats ...
Breaking Medicine Technology:Mallinckrodt plc Announces Share Repurchase Program 2Mallinckrodt plc Announces Share Repurchase Program 3Mallinckrodt plc Announces Share Repurchase Program 4Heptares Scientists to Receive the Malcolm Campbell Memorial Prize for 2015 in Recognition of Their Outstanding Contribution to GPCR Drug Discovery 2Heptares Scientists to Receive the Malcolm Campbell Memorial Prize for 2015 in Recognition of Their Outstanding Contribution to GPCR Drug Discovery 3Heptares Scientists to Receive the Malcolm Campbell Memorial Prize for 2015 in Recognition of Their Outstanding Contribution to GPCR Drug Discovery 4ITOCHU Named the Exclusive Distributor for ViewRay's MRI-Guided Radiation Therapy System in Japan 2
... Furthering its commitment to provide patients ... B. Braun Medical Inc. (B. Braun) today announced ... Amerinet Inc., a leading national healthcare group purchasing organization. ... ) , Effective November 1, the new five-year agreement ...
... NEW YORK, Oct. 20 Code Blue, billed as ... the body combat dehydration, replenish vital nutrients, remove harmful ... L-Alanyl-L-Glutamine from Kyowa Hakko USA in the formulation. , ... all natural powerful ingredients in Code Blue allow you ...
Cached Medicine Technology:B. Braun and Amerinet Sign to Expand Infusion Therapy Offerings 2B. Braun and Amerinet Sign to Expand Infusion Therapy Offerings 3Code Blue Recovery Drink Features Sustamine(TM) from Kyowa Hakko 2
Cemented foundation 450 series....
A cementless femoral stem that promotes bone in-growth and reduces thigh pain....
The link ribbed hip stem for cementless primary hip replacement surgery....
The cemented hip joint prosthesis system....
Medicine Products: